ID

26729

Beschrijving

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Liver events

Trefwoorden

Versies (5)
  1. 11-10-17 11-10-17 -
  2. 16-10-17 16-10-17 -
  3. 16-10-17 16-10-17 -
  4. 23-10-17 23-10-17 -
  5. 11-01-18 11-01-18 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

23 oktober 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

Engels

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulieren  
1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
Beschrijving

1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?

[1] ALT (alanine aminotransferase)
Beschrijving

alanine aminotransferase

Datatype

boolean

[2] AST (aspartate aminotransferase)
Beschrijving

aspartate aminotransferase

Datatype

boolean

[3] Total bilirubin
Beschrijving

Total bilirubin

Datatype

boolean

[4] Alkaline phosphatase
Beschrijving

Alkaline phosphatase

Datatype

boolean

[OT] Other
Beschrijving

Other liver chemistry result

Datatype

boolean

Liver events
Beschrijving

Liver events

2. Is the subject age 55 or older?
Beschrijving

subject age

Datatype

boolean

3. If female, is the subject pregnant?
Beschrijving

If yes, ensure Pregnancy Notification Form has been completed.

Datatype

text

4. Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Beschrijving

diagnostic imaging of liver or hepatobiliary system

Datatype

boolean

4. If diagnostic imaging tests were performed, were the results normal?
Beschrijving

If No, record the details on the Non-Serious Adverse Events form or Serious Adverse Event form.

Datatype

boolean

5. Were any liver biopsies performed?
Beschrijving

If yes, complete Liver Biopsy form.

Datatype

boolean

6. Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Beschrijving

If yes, record on the appropriate Concomitant Medication form.

Datatype

boolean

7. Did the subject fast or undergo significant dietary change in the past week?
Beschrijving

dietary change

Datatype

boolean

Evaluation interval code
Beschrijving

[hidden]

Datatype

text

Terug naar het begin van de pagina

Similar models

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
alanine aminotransferase
Item
[1] ALT (alanine aminotransferase)
boolean
aspartate aminotransferase
Item
[2] AST (aspartate aminotransferase)
boolean
Total bilirubin
Item
[3] Total bilirubin
boolean
Alkaline phosphatase
Item
[4] Alkaline phosphatase
boolean
Other liver chemistry result
Item
[OT] Other
boolean
Item Group
Liver events
subject age
Item
2. Is the subject age 55 or older?
boolean
Item
3. If female, is the subject pregnant?
text
subject pregnant
Code List
3. If female, is the subject pregnant?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not applicable (X)
diagnostic imaging of liver or hepatobiliary system
Item
4. Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
boolean
diagnostic imaging of liver or hepatobiliary system results
Item
4. If diagnostic imaging tests were performed, were the results normal?
boolean
liver biopsies
Item
5. Were any liver biopsies performed?
boolean
complementary or alternative medicines, supplements, illicit drugs
Item
6. Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
boolean
dietary change
Item
7. Did the subject fast or undergo significant dietary change in the past week?
boolean
Evaluation interval code
Item
Evaluation interval code
text
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial